High-affinity inhibitors of large protein–protein
interactions often have a high molecular weight, which
compromises their cell permeability and oral bioavailability.
We recently presented isomer-free, strain-promoted azidealkyne
cycloaddition (iSPAAC) as a method by which to
generate large, chemically uniform bioactive molecules inside
living cells from two smaller components with higher cell
permeability. Here, we present the synthesis of Fmocprotected
azacyclonon-5-yne (Fmoc-ACN) as the first cyclononyne
suitable for iSPAAC. ACN facilitated the structureguided
development of a single-digit micromolar triazole
inhibitor of the protein–protein interaction domain of the
antiapoptotic protein Bcl-xL. Inhibitor formation in aqueous
buffer at 37°C, templated by the target protein Bcl-xL,
proceeded 2800 times faster than the reaction between
Fmoc-ACN and benzyl azide under standard conditions in
acetonitrile. Our data demonstrate the utility of cyclononynes
for iSPAAC and their potential for achieving vastly accelerated
templated reactions in aqueous environments
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.